Wioletta Pękala

857 total citations
15 papers, 689 citations indexed

About

Wioletta Pękala is a scholar working on Molecular Biology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Wioletta Pękala has authored 15 papers receiving a total of 689 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Genetics and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Wioletta Pękala's work include BRCA gene mutations in cancer (5 papers), Estrogen and related hormone effects (4 papers) and DNA Repair Mechanisms (3 papers). Wioletta Pękala is often cited by papers focused on BRCA gene mutations in cancer (5 papers), Estrogen and related hormone effects (4 papers) and DNA Repair Mechanisms (3 papers). Wioletta Pękala collaborates with scholars based in Poland, Sweden and Germany. Wioletta Pękala's co-authors include Ewa Grzybowska, Jolanta Pamuła‐Piłat, Kari Hemminki, Asta Försti, Helena Zientek, Qianren Jin, Rüdiger Klaes, Per Lenner, Kerstin Enquist and B. Utracka-Hutka and has published in prestigious journals such as Clinical Cancer Research, International Journal of Cancer and Breast Cancer Research and Treatment.

In The Last Decade

Wioletta Pękala

15 papers receiving 674 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wioletta Pękala Poland	11	505	230	192	164	95	15	689
Helena Zientek Poland	11	518 1.0×	218 0.9×	190 1.0×	212 1.3×	105 1.1×	15	690
Alfons Meindl Germany	12	459 0.9×	146 0.6×	224 1.2×	317 1.9×	80 0.8×	17	769
K. J. Cullen United States	7	360 0.7×	157 0.7×	241 1.3×	159 1.0×	42 0.4×	7	622
Maria Stella Pennisi Italy	14	294 0.6×	136 0.6×	187 1.0×	58 0.4×	91 1.0×	34	798
Anna Berg Norway	16	287 0.6×	150 0.7×	167 0.9×	88 0.5×	83 0.9×	21	683
Maureen Sadim United States	13	420 0.8×	200 0.9×	274 1.4×	85 0.5×	114 1.2×	18	764
Saradhi Mallampati United States	14	275 0.5×	81 0.4×	155 0.8×	110 0.7×	34 0.4×	34	592
Cristina Bilbao Spain	12	203 0.4×	94 0.4×	101 0.5×	79 0.5×	91 1.0×	31	456
Tamara Aleksic United Kingdom	15	454 0.9×	219 1.0×	245 1.3×	62 0.4×	50 0.5×	18	786
Federica Torricelli Italy	18	471 0.9×	212 0.9×	208 1.1×	137 0.8×	64 0.7×	80	1.0k

Countries citing papers authored by Wioletta Pękala

Since Specialization

Citations

This map shows the geographic impact of Wioletta Pękala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wioletta Pękala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wioletta Pękala more than expected).

Fields of papers citing papers by Wioletta Pękala

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wioletta Pękala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wioletta Pękala. The network helps show where Wioletta Pękala may publish in the future.

Co-authorship network of co-authors of Wioletta Pękala

This figure shows the co-authorship network connecting the top 25 collaborators of Wioletta Pękala. A scholar is included among the top collaborators of Wioletta Pękala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wioletta Pękala. Wioletta Pękala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Grzybowska, Ewa, Robert Johansson, Kerstin Enquist, et al.. (2009). A functional promoter polymorphism in the TERT gene does not affect inherited susceptibility to breast cancer. Cancer Genetics and Cytogenetics. 190(2). 71–74. 32 indexed citations

Wagner, Kerstin, Ewa Grzybowska, Dorota Butkiewicz, et al.. (2007). High-throughput genotyping of a common deletion polymorphism disrupting the TRY6 gene and its association with breast cancer risk. BMC Genetics. 8(1). 41–41. 5 indexed citations

Försti, Asta, Qianren Jin, Andrea Altieri, et al.. (2006). Polymorphisms in the KDR and POSTN Genes: Association with Breast Cancer Susceptibility and Prognosis. Breast Cancer Research and Treatment. 101(1). 83–93. 54 indexed citations

Pamuła‐Piłat, Jolanta, Małgorzata Krześniak, Helena Zientek, et al.. (2006). Functional Impact of Sequence Alterations Found in BRCA1 Promoter/5'UTR Region in Breast/Ovarian Cancer Families from Upper Silesia, Poland. Hereditary Cancer in Clinical Practice. 4(1). 20–4. 5 indexed citations

Jarząb, Michał, Ewa Chmielik, Krzysztof Simek, et al.. (2006). Gene Expression Profiling in Hereditary, BRCA1-linked Breast Cancer: Preliminary Report. Hereditary Cancer in Clinical Practice. 4(1). 28–28. 12 indexed citations

Wirtenberger, Michael, Kari Hemminki, Asta Försti, et al.. (2005). c-MYC Asn11Ser is associated with increased risk for familial breast cancer. International Journal of Cancer. 117(4). 638–642. 10 indexed citations

Wagner, Kerstin, Kari Hemminki, Elisabeth Israelsson, et al.. (2005). Polymorphisms in the IGF-1 and IGFBP3 promoter and the risk of breast cancer. Breast Cancer Research and Treatment. 92(2). 133–140. 39 indexed citations

Jin, Qianren, Kari Hemminki, Kerstin Enquist, et al.. (2005). Vascular Endothelial Growth Factor Polymorphisms in Relation to Breast Cancer Development and Prognosis. Clinical Cancer Research. 11(10). 3647–3653. 207 indexed citations

Burwinkel, Barbara, Michael Wirtenberger, Bernd Frank, et al.. (2005). Association of NCOA3 (AIB1) polymorphisms with breast cancer risk. Breast Cancer Research. 7(S2). 1 indexed citations

10.

Hemminki, Kari, Elisabeth Israelsson, Ewa Grzybowska, et al.. (2005). Association of polymorphisms and haplotypes in the human growth hormone 1 (GH1) gene with breast cancer. Endocrine Related Cancer. 12(4). 917–928. 18 indexed citations

11.

Wagner, Kerstin, Kari Hemminki, Ewa Grzybowska, et al.. (2005). Polymorphisms in the growth hormone receptor: A case‐control study in breast cancer. International Journal of Cancer. 118(11). 2903–2906. 17 indexed citations

12.

Wilkening, Stefan, Barbara Burwinkel, Ewa Grzybowska, et al.. (2005). Polyglutamine Repeat Length in the NCOA3 Does Not Affect Risk in Familial Breast Cancer. Cancer Epidemiology Biomarkers & Prevention. 14(1). 291–292. 9 indexed citations

13.

Burwinkel, Barbara, Michael Wirtenberger, Rüdiger Klaes, et al.. (2005). Association of NCOA3 Polymorphisms with Breast Cancer Risk. Clinical Cancer Research. 11(6). 2169–2174. 40 indexed citations

14.

Jin, Qianren, Kari Hemminki, Ewa Grzybowska, et al.. (2004). Polymorphisms and haplotype structures in genes for transforming growth factor β1 and its receptors in familial and unselected breast cancers. International Journal of Cancer. 112(1). 94–99. 82 indexed citations

15.

Försti, Asta, Sabrina Angelini, Somali Sanyal, et al.. (2004). Single nucleotide polymorphisms in breast cancer. Oncology Reports. 11(4). 917–22. 158 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact